Peripheral blood monocytes are plastic cells that migrate to tissues and differentiate into various cell types, including macrophages, dendritic cells, and osteoclasts. We have described the migration of cellular inhibitor of apoptosis protein 1 (cIAP1), a member of the IAP family of proteins, from the nucleus to the Golgi apparatus in monocytes undergoing differentiation into macrophages. Here we show that, once in the cytoplasm, cIAP1 is involved in the degradation of the adaptor protein tumor necrosis factor receptorassociated factor 2 (TRAF2) by the proteosomal machinery. Inhibition of cIAP1 prevents the decrease in TRAF2 expression that characterizes macrophage formation. We demonstrate that TRAF2 is initially required for macrophage differentiation as its silencing prevents I-B␣ degradation, nuclear factor-B (NF-B) p65 nuclear translocation, and the differentiation process. Then, we show that cIAP1-mediated degradation of TRAF2 allows the differentiation process to progress. This degradation is required for the macrophages to be fully functional as TRAF2 overexpression in differentiated cells decreases the c-Jun N-terminal kinasemediated synthesis and the secretion of proinflammatory cytokines, such as interleukin-8 and monocyte chemoattractant protein 1 (MCP-1) in response to CD40 ligand. We conclude that TRAF2 expression and subsequent degradation are required for the differentiation of monocytes into fully functional macrophages.
IntroductionTumor necrosis factor receptor (TNFR)-associated factors (TRAFs) form an evolutionarily conserved family of intracellular adaptors that bind directly or indirectly to members of the TNFR and the interleukin-1 (IL-1)/Toll-like receptor (TLR) families. 1,2 They participate in the transduction of signals from these receptors to downstream events that regulate cell proliferation, differentiation, and death.The member of this family known as TRAF2 directly binds CD27, CD30, CD40, CD137, TNFR2, and receptor activator of nuclear factor-B (RANK). TRAF2 can also bind TNFR1 indirectly, through interaction with TNFR-associated death domain protein. 3 On receptor engagement, TRAF2 is recruited in a receptorassociated multiprotein complex [4][5][6] where it contributes to stimulate specific downstream signaling pathways. Depending on cell type, differentiation stage, and stimulated receptors, these signaling pathways can involve c-jun N-terminal kinase (JNK), nuclear factor B (NF-B), and p38 mitogen-activated protein kinase (p38MAPK). 4,5,[7][8][9] TRAF2 is also a key regulator of TNFR1-mediated apoptosis. 10-13 TRAF2 activity is regulated by its interaction with protein partners, such as TRAF1, 14-16 subcellular localization, 7,8,15 ubiquitylation, and degradation by the proteasome pathway. 8,12,13,[17][18][19] A yeast 2-hybrid screen of proteins able to bind TRAF2 identified a direct interaction with cIAP1 (cellular inhibitor of apoptosis protein 1, also named BIRC2, HIAP2), a member of the IAP family of proteins. 20,21 Thanks to the presence of a C-terminal zinc finger domai...